G

Generation Bio Co
D

GBIO

5.60000
USD
-0.03
(-0.53%)
مغلق
حجم التداول
86
الربح لكل سهم
1
العائد الربحي
-
P/E
-1
حجم السوق
37,735,852
أصول ذات صلة المقالات

العنوان: Generation Bio Co

القطاع: Healthcare
الصناعة: Biotechnology
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.